166 related articles for article (PubMed ID: 7862624)
41. Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent.
Forrester K; Lupold SE; Ott VL; Chay CH; Band V; Wang XW; Harris CC
Oncogene; 1995 Jun; 10(11):2103-11. PubMed ID: 7784055
[TBL] [Abstract][Full Text] [Related]
42. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
[TBL] [Abstract][Full Text] [Related]
43. Identification of novel p53 target genes by cDNA AFLP in glioblastoma cells.
Saffari M; Dinehkabodi OS; Ghaffari SH; Modarressi MH; Mansouri F; Heidari M
Cancer Lett; 2009 Jan; 273(2):316-22. PubMed ID: 18814959
[TBL] [Abstract][Full Text] [Related]
44. Endothelial cells co-cultured with wild-type and dominant/negative p53-transfected glioblastoma cells exhibit differential sensitivity to radiation-induced apoptosis.
Khodarev NN; Labay E; Darga T; Yu J; Mauceri H; Gupta N; Kataoka Y; Weichselbaum RR
Int J Cancer; 2004 Mar; 109(2):214-9. PubMed ID: 14750172
[TBL] [Abstract][Full Text] [Related]
45. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
[TBL] [Abstract][Full Text] [Related]
46. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells.
Kagawa S; Fujiwara T; Hizuta A; Yasuda T; Zhang WW; Roth JA; Tanaka N
Oncogene; 1997 Oct; 15(16):1903-9. PubMed ID: 9365236
[TBL] [Abstract][Full Text] [Related]
47. [Clinical and pathological significance of p53 gene mutation in human cerebral glioblastoma multiforme].
Matsumoto R
Hokkaido Igaku Zasshi; 1998 Jul; 73(4):407-17. PubMed ID: 9828926
[TBL] [Abstract][Full Text] [Related]
48. Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population.
Yamada H; Shinmura K; Okudela K; Goto M; Suzuki M; Kuriki K; Tsuneyoshi T; Sugimura H
Carcinogenesis; 2007 Sep; 28(9):2013-8. PubMed ID: 17690113
[TBL] [Abstract][Full Text] [Related]
49. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
Lang FF; Miller DC; Koslow M; Newcomb EW
J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
[TBL] [Abstract][Full Text] [Related]
50. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
[TBL] [Abstract][Full Text] [Related]
51. Early ultraviolet B-induced G1 arrest and suppression of the malignant phenotype by wild-type p53 in human squamous cell carcinoma cells.
Courtois SJ; Woodworth CD; Degreef H; Garmyn M
Exp Cell Res; 1997 May; 233(1):135-44. PubMed ID: 9184083
[TBL] [Abstract][Full Text] [Related]
52. Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53.
Yonish-Rouach E; Deguin V; Zaitchouk T; Breugnot C; Mishal Z; Jenkins JR; May E
Oncogene; 1995 Dec; 11(11):2197-205. PubMed ID: 8570169
[TBL] [Abstract][Full Text] [Related]
53. Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model.
Hesselager G; Uhrbom L; Westermark B; Nistér M
Cancer Res; 2003 Aug; 63(15):4305-9. PubMed ID: 12907595
[TBL] [Abstract][Full Text] [Related]
54. Overexpression of deletion-mutant epidermal growth factor receptor is associated with altered genotoxic stress-provoked p53 mRNA induction in a human glioblastoma cell line.
Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
Anticancer Res; 2001; 21(1A):189-95. PubMed ID: 11299733
[TBL] [Abstract][Full Text] [Related]
55. TP53 mutations in malignant astrocytomas.
Biernat W; Debiec-Rychter M; Kordek R; Liberski PP
Pol J Pathol; 1997; 48(4):221-4. PubMed ID: 9529927
[TBL] [Abstract][Full Text] [Related]
56. Mutant p53 is not fully dominant over endogenous wild type p53 in a colorectal adenoma cell line as demonstrated by induction of MDM2 protein and retention of a p53 dependent G1 arrest after gamma irradiation.
Williams AC; Miller JC; Collard TJ; Bracey TS; Cosulich S; Paraskeva C
Oncogene; 1995 Jul; 11(1):141-9. PubMed ID: 7624121
[TBL] [Abstract][Full Text] [Related]
57. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD
Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706
[TBL] [Abstract][Full Text] [Related]
58. Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells.
Ueba T; Nosaka T; Takahashi JA; Shibata F; Florkiewicz RZ; Vogelstein B; Oda Y; Kikuchi H; Hatanaka M
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9009-13. PubMed ID: 8090761
[TBL] [Abstract][Full Text] [Related]
59. Clonal expansion of p53 mutant cells is associated with brain tumour progression.
Sidransky D; Mikkelsen T; Schwechheimer K; Rosenblum ML; Cavanee W; Vogelstein B
Nature; 1992 Feb; 355(6363):846-7. PubMed ID: 1311419
[TBL] [Abstract][Full Text] [Related]
60. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
Takimoto R; El-Deiry WS
Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
